Double-click
Select to translate
- frikaans
- Albanian – shqipe
- Arabic – العربية
- Armenian – Հայերէն
- Azerbaijani – azərbaycanca
- Basque – euskara
- Belarusian – беларуская
- Bengali – বাংলা
- Bulgarian – български
- Catalan – català
- Chinese – 中文(简体中文)
- Chinese – 中文 (繁體中文)
- Croatian – hrvatski
- Czech – čeština
- Danish – dansk
- Dutch – Nederlands
- English
- Esperanto – esperanto
- Estonian – eesti
- Filipino
- Finnish – suomi
- French – français
- Galician – galego
- Georgian – ქართული
- German – Deutsch
- Greek – Ελληνικά
- Gujarati – ગુજરાતી
- Haitian Creole – kreyòl ayisyen
- Hebrew – עברית
- Hindi – हिन्दी
- Hungarian – magyar
- Icelandic – íslenska
- Indonesian – Bahasa Indonesia
- Irish – Gaeilge
- Italian – italiano
- Japanese – 日本語
- Kannada – ಕನ್ನಡ
- Korean – 한국어
- Latin – Lingua Latina
- Latvian – latviešu
- Lithuanian – lietuvių
- Macedonian – македонски
- Malay – Bahasa Melayu
- Maltese – Malti
- Norwegian – norsk
- Persian – فارسی
- Polish – polski
- Portuguese – português
- Romanian – română
- Russian – русский
- Serbian – Српски
- Slovak – slovenčina
- Slovenian – slovenščina
- Spanish – español
- Swahili – Kiswahili
- Swedish – svenska
- Tamil – தமிழ்
- Telugu – తెలుగు
- Thai – ไทย
- Turkish – Türkçe
- Ukrainian – українська
- Urdu – اردو
- Vietnamese – Tiếng Việt
- Welsh – Cymraeg
- Yiddish – יידיש
Research and Innovation Departments
In the wake of the post-pandemic era, our Research and Innovation departments are dedicated to advancing science and innovation both nationally and internationally. We are eager to develop our ideas and contribute to the future of ophthalmology.
Our Objectives:
-
Pioneering New Solutions
We aim to create something that has never been made before, pushing the boundaries of what is possible in ophthalmic care.
-
Identifying Patient Needs
Our focus is on identifying the specific needs related to ophthalmology, particularly for patients requiring vision improvement.
-
Adaptability to Changing Conditions
We prioritize the ability to adapt our approaches and solutions to meet evolving healthcare environments and patient needs.
-
Addressing New Challenges
Our processes are designed to tackle new challenges as they arise, ensuring that we remain at the forefront of innovation.
-
Patient Awareness and Utilization
We strive to facilitate the process of patients becoming aware of and effectively using our products and processes, ensuring they receive the maximum benefit.
-
Innovative Integration
Our goal is to create improvements through the innovative integration of existing components, which may not all be novel, to produce enhanced outcomes in patient care.
-
Collaboration with Academic Institutions
We seek to strengthen the connection between academic research organizations and our specialists to enhance knowledge transfer, improve practices, and inform our innovative processes.
Progress and Innovation in Ophthalmology
-
Minimally Invasive Surgery:
Advancements in surgical techniques, such as minimally invasive vitrectomy and micro-incision cataract surgery, have greatly reduced recovery times and improved outcomes for patients. These procedures use tiny instruments and precise technology to treat eye conditions with minimal discomfort and quicker recovery periods.
-
Laser and Refractive Surgery:
Laser technologies, including LASIK and SMILE (Small Incision Lenticule Extraction), have revolutionized corrective surgery for refractive errors such as myopia, hyperopia, and astigmatism. These procedures have become safer, more precise, and more accessible, allowing millions to reduce or eliminate the need for glasses or contact lenses.
-
Artificial Intelligence and Machine Learning:
AI is increasingly being used to diagnose eye conditions like diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD). Automated systems can analyze imaging data faster and more accurately, helping ophthalmologists detect diseases early and personalize treatment plans.
-
Retinal Imaging and Diagnostics:
Innovations like Optical Coherence Tomography (OCT) and fundus photography provide high-resolution images of the retina and optic nerve. These tools allow for earlier diagnosis and monitoring of diseases such as glaucoma, AMD, and diabetic retinopathy, enabling timely intervention and treatment.
-
Gene Therapy and Regenerative Medicine:
Gene therapies, such as Luxturna, have emerged to treat genetic eye conditions, like inherited retinal diseases, by correcting defective genes. Regenerative medicine is also showing promise, with research into stem cell therapies that could potentially restore vision in patients with retinal degeneration.
-
Nanotechnology:
Nanotechnology is playing a crucial role in drug delivery systems for eye care, improving the efficiency of medications and targeting specific tissues more effectively. Nano-scale particles can cross barriers in the eye to deliver therapeutic agents directly to affected areas, reducing side effects and enhancing treatment outcomes.
-
Vitreoretinal and Anterior Segment Innovations:
Advances in vitreoretinal surgery have improved the management of retinal detachments, macular holes, and diabetic eye disease. Similarly, new developments in anterior segment surgeries, such as corneal transplants and artificial corneas, have made it possible to treat complex cases with higher success rates.
-
Teleophthalmology:
Telemedicine has expanded into ophthalmology, allowing patients to receive consultations and even screenings remotely. This has been particularly important in reaching underserved or remote populations who lack access to specialized eye care.
-
Implantable Devices:
The development of innovative implantable devices, such as retinal implants and intraocular lenses (IOLs), has transformed treatment for severe visual impairments and conditions like cataracts. These devices help restore vision and offer patients long-term solutions for maintaining or improving sight.
-
Personalized Medicine:
Precision medicine is allowing for more personalized approaches to treating eye diseases, tailoring treatments to an individual’s genetic makeup and specific condition. This innovation is particularly beneficial for complex conditions like glaucoma and macular degeneration, where treatments can be adapted to the patient’s unique needs.